The increasing prevalence of urinary tract disorders, benign prostatic hyperplasia (BPH), overactive bladder, urinary incontinence, and recurrent urinary tract infections is driving sustained growth in the Urological Medications Market. Urological medications include alpha blockers, anticholinergics, antibiotics, phosphodiesterase inhibitors, and 5-alpha reductase inhibitors that help manage a...